NMIBC
Clinical trials for NMIBC explained in plain language.
Never miss a new study
Get alerted when new NMIBC trials appear
Sign up with your email to follow new studies for NMIBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New bladder cancer drug shows promise in early trial
Disease control CompletedThis early-phase study tested a new drug called UGN-301 (zalifrelimab) in 51 people with recurrent non-muscle invasive bladder cancer. The goal was to check the drug's safety and find the best dose when given directly into the bladder, alone or with other treatments. Results will…
Matched conditions: NMIBC
Phase: PHASE1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated May 26, 2026 09:21 UTC
-
Bladder cancer patients get new hope from Virus-Based therapy
Disease control CompletedThis study tested a new treatment called VG161, a virus designed to attack cancer cells, for people with a type of bladder cancer that did not get better with standard therapy. The virus was given directly into the bladder through a tube. The main goals were to see if it is safe,…
Matched conditions: NMIBC
Phase: PHASE1, PHASE2 • Sponsor: Ding-Wei Ye • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
Could a pill wipe out bladder tumors before surgery?
Disease control CompletedThis study tested a drug called pemigatinib in 30 people with a type of bladder cancer that keeps coming back. Participants took the drug for 4-6 weeks before their scheduled surgery to remove the tumor. The goal was to see if the drug could completely eliminate the cancer before…
Matched conditions: NMIBC
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 18, 2026 11:58 UTC